Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysis

BackgroundPatients with severe acute kidney injury (AKI) may require renal replacement therapy (RRT), such as hemodialysis and peritoneal dialysis. Neutrophil gelatinase-associated lipocalin (NGAL) is a sensitive indicator for early diagnosis and recognition of AKI; however, its predictive value of...

Full description

Bibliographic Details
Main Authors: Chunhua Xu, Shan Lin, Longyi Mao, Zesong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.859318/full
_version_ 1811183674497957888
author Chunhua Xu
Chunhua Xu
Chunhua Xu
Shan Lin
Shan Lin
Longyi Mao
Zesong Li
author_facet Chunhua Xu
Chunhua Xu
Chunhua Xu
Shan Lin
Shan Lin
Longyi Mao
Zesong Li
author_sort Chunhua Xu
collection DOAJ
description BackgroundPatients with severe acute kidney injury (AKI) may require renal replacement therapy (RRT), such as hemodialysis and peritoneal dialysis. Neutrophil gelatinase-associated lipocalin (NGAL) is a sensitive indicator for early diagnosis and recognition of AKI; however, its predictive value of AKI-associated need for RRT needs further evaluation.MethodsFollowing the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, relevant articles were systematically searched and selected from seven databases. The random effects model was applied to evaluate the predictive performance of NGAL for AKI requiring RRT. The Newcastle–Ottawa Scale (NOS) was used to assess the quality of each included study.ResultsA total of 18 studies including 1,787 patients with AKI and having an average NOS score of 7.67 were included in the meta-analysis. For plasma/serum NGAL, the pooled sensitivity and specificity with corresponding 95% confidence interval (CI) were 0.75 (95% CI: 0.68–0.81) and 0.76 (95% CI: 0.70–0.81), respectively. The pooled positive likelihood ratio (PLR) was 2.9 (95% CI: 2.1–4.1), and the pooled negative likelihood ratio (NLR) was 0.34 (95% CI: 0.25–0.46). Subsequently, the pooled diagnostic odds ratio (DOR) was 9 (95% CI: 5–16) using a random effects model, and the area under the curve (AUC) of summary receiver operating characteristic to summarize predictive accuracy was 0.82 (95% CI: 0.79–0.85). For urine NGAL, the pooled sensitivity, specificity, PLR, NLR, DOR, and AUC values were 0.78 (95% CI: 0.61–0.90), 0.77 (95% CI: 0.65–0.85), 3.4 (95% CI: 2.4–4.8), 0.28 (95% CI: 0.15–0.52), 12 (95% CI: 6–24), and 0.84 (95% CI: 0.80–0.87), respectively.ConclusionPlasma/serum and urine NGAL levels performed comparably well in predicting AKI requiring RRT. Our findings suggested that NGAL is an effective predictive biomarker for the AKI-associated need for RRT. Nevertheless, more pieces of high-quality evidence and future trials with larger sample sizes are needed for further improvement of patient outcomes.Systematic review registration[https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022346595], identifier [CRD42022346595].
first_indexed 2024-04-11T09:50:41Z
format Article
id doaj.art-6f6fc5c9cd4143d497f75bb3f2f4b737
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-11T09:50:41Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-6f6fc5c9cd4143d497f75bb3f2f4b7372022-12-22T04:30:49ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-09-01910.3389/fmed.2022.859318859318Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysisChunhua Xu0Chunhua Xu1Chunhua Xu2Shan Lin3Shan Lin4Longyi Mao5Zesong Li6Guangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen Key Laboratory of Genitourinary Tumor, Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital (Shenzhen Institute of Translational Medicine), Shenzhen, Guangdong, ChinaGuangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, Shenzhen University Health Science Center, School of Biomedical Engineering, Shenzhen, Guangdong, ChinaShulan International Medical College, Zhejiang Shuren University, Hangzhou, ChinaGuangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen Key Laboratory of Genitourinary Tumor, Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital (Shenzhen Institute of Translational Medicine), Shenzhen, Guangdong, ChinaDepartment of Central Laboratory, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, Guangdong, ChinaGuangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen Key Laboratory of Genitourinary Tumor, Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital (Shenzhen Institute of Translational Medicine), Shenzhen, Guangdong, ChinaGuangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen Key Laboratory of Genitourinary Tumor, Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital (Shenzhen Institute of Translational Medicine), Shenzhen, Guangdong, ChinaBackgroundPatients with severe acute kidney injury (AKI) may require renal replacement therapy (RRT), such as hemodialysis and peritoneal dialysis. Neutrophil gelatinase-associated lipocalin (NGAL) is a sensitive indicator for early diagnosis and recognition of AKI; however, its predictive value of AKI-associated need for RRT needs further evaluation.MethodsFollowing the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, relevant articles were systematically searched and selected from seven databases. The random effects model was applied to evaluate the predictive performance of NGAL for AKI requiring RRT. The Newcastle–Ottawa Scale (NOS) was used to assess the quality of each included study.ResultsA total of 18 studies including 1,787 patients with AKI and having an average NOS score of 7.67 were included in the meta-analysis. For plasma/serum NGAL, the pooled sensitivity and specificity with corresponding 95% confidence interval (CI) were 0.75 (95% CI: 0.68–0.81) and 0.76 (95% CI: 0.70–0.81), respectively. The pooled positive likelihood ratio (PLR) was 2.9 (95% CI: 2.1–4.1), and the pooled negative likelihood ratio (NLR) was 0.34 (95% CI: 0.25–0.46). Subsequently, the pooled diagnostic odds ratio (DOR) was 9 (95% CI: 5–16) using a random effects model, and the area under the curve (AUC) of summary receiver operating characteristic to summarize predictive accuracy was 0.82 (95% CI: 0.79–0.85). For urine NGAL, the pooled sensitivity, specificity, PLR, NLR, DOR, and AUC values were 0.78 (95% CI: 0.61–0.90), 0.77 (95% CI: 0.65–0.85), 3.4 (95% CI: 2.4–4.8), 0.28 (95% CI: 0.15–0.52), 12 (95% CI: 6–24), and 0.84 (95% CI: 0.80–0.87), respectively.ConclusionPlasma/serum and urine NGAL levels performed comparably well in predicting AKI requiring RRT. Our findings suggested that NGAL is an effective predictive biomarker for the AKI-associated need for RRT. Nevertheless, more pieces of high-quality evidence and future trials with larger sample sizes are needed for further improvement of patient outcomes.Systematic review registration[https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022346595], identifier [CRD42022346595].https://www.frontiersin.org/articles/10.3389/fmed.2022.859318/fullneutrophil gelatinase-associated lipocalinacute kidney injuryrenal replacement therapypredictive valuesystematic review and meta-analysis
spellingShingle Chunhua Xu
Chunhua Xu
Chunhua Xu
Shan Lin
Shan Lin
Longyi Mao
Zesong Li
Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysis
Frontiers in Medicine
neutrophil gelatinase-associated lipocalin
acute kidney injury
renal replacement therapy
predictive value
systematic review and meta-analysis
title Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysis
title_full Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysis
title_fullStr Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysis
title_full_unstemmed Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysis
title_short Neutrophil gelatinase-associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy: A systematic review and meta-analysis
title_sort neutrophil gelatinase associated lipocalin as predictor of acute kidney injury requiring renal replacement therapy a systematic review and meta analysis
topic neutrophil gelatinase-associated lipocalin
acute kidney injury
renal replacement therapy
predictive value
systematic review and meta-analysis
url https://www.frontiersin.org/articles/10.3389/fmed.2022.859318/full
work_keys_str_mv AT chunhuaxu neutrophilgelatinaseassociatedlipocalinaspredictorofacutekidneyinjuryrequiringrenalreplacementtherapyasystematicreviewandmetaanalysis
AT chunhuaxu neutrophilgelatinaseassociatedlipocalinaspredictorofacutekidneyinjuryrequiringrenalreplacementtherapyasystematicreviewandmetaanalysis
AT chunhuaxu neutrophilgelatinaseassociatedlipocalinaspredictorofacutekidneyinjuryrequiringrenalreplacementtherapyasystematicreviewandmetaanalysis
AT shanlin neutrophilgelatinaseassociatedlipocalinaspredictorofacutekidneyinjuryrequiringrenalreplacementtherapyasystematicreviewandmetaanalysis
AT shanlin neutrophilgelatinaseassociatedlipocalinaspredictorofacutekidneyinjuryrequiringrenalreplacementtherapyasystematicreviewandmetaanalysis
AT longyimao neutrophilgelatinaseassociatedlipocalinaspredictorofacutekidneyinjuryrequiringrenalreplacementtherapyasystematicreviewandmetaanalysis
AT zesongli neutrophilgelatinaseassociatedlipocalinaspredictorofacutekidneyinjuryrequiringrenalreplacementtherapyasystematicreviewandmetaanalysis